Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...

Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...

Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...

The head of the U.S. Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical ...

Prasad has long criticized the FDA for granting emergency use authorization for COVID-19 vaccine boosters, saying last year that Marks was "either incompetent or corrupt to authorize a booster ...